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Structure of a Calcium-dependent 11R-Lipoxygenase
Suggests a Mechanism for Ca2ⴙ Regulation*□
S
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Priit Eek‡, Reet Järving‡, Ivar Järving‡, Nathaniel C. Gilbert§, Marcia E. Newcomer§, and Nigulas Samel‡1
From the ‡Department of Chemistry, Tallinn University of Technology, Akadeemia tee 15, 12618 Tallinn, Estonia and the
§
Department of Biological Sciences, Louisiana State University, Baton Rouge, Lousiana 70803
Background: Lipoxygenases vary in their catalytic specificity and regulation.
Results: 11R-LOX, strictly Ca2⫹-dependent, displays novel structural features in the membrane-binding domain.
Conclusion: A model for how access to an enclosed active site is linked to Ca2⫹-dependent membrane binding is proposed.
Significance: The 11R-LOX model provides structural insights into the allosteric regulation of lipoxygenases.
Lipoxygenases (LOXs) are a key part of several signaling pathways that lead to inflammation and cancer. Yet, the mechanisms
of substrate binding and allosteric regulation by the various
LOX isoforms remain speculative. Here we report the 2.47-Å
resolution crystal structure of the arachidonate 11R-LOX from
Gersemia fruticosa, which sheds new light on the mechanism of
LOX catalysis. Our crystallographic and mutational studies suggest that the aliphatic tail of the fatty acid is bound in a hydrophobic pocket with two potential entrances. We speculate that
LOXs share a common T-shaped substrate channel architecture
that gives rise to the varying positional specificities. A general
allosteric mechanism is proposed for transmitting the activityinducing effect of calcium binding from the membrane-targeting PLAT (polycystin-1/lipoxygenase/␣-toxin) domain to the
active site via a conserved -cation bridge.

Lipoxygenases (LOXs)2 are non-heme iron dioxygenases
that catalyze the stereo- and regiospecific hydroperoxidation of
polyunsaturated fatty acids (1). LOX catalysis products of
arachidonic acid (AA), which is the main substrate in animals,
are hydroperoxyeicosatetraenoic acids (HpETEs), these lipid
mediators and their metabolites have been implicated in cancer
(2), atherosclerosis (3), and allergic inflammation (4). Consequently, LOXs are targets for drug design. A complicating factor in the development of LOX inhibitors is that there are several LOX isoforms in an organism, all with equivalent catalytic
machinery and chemical mechanism (5). Thus, differences in
regiospecificity or regulation must be exploited to design iso-
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form-specific inhibitors. Given the limited amount of structural
information of arachidonate-metabolizing LOXs, each new
structure provides crucial details related to LOX catalysis
mechanism.
LOX catalysis begins with a stereoselective hydrogen
abstraction by the catalytic non-heme iron from the methylene
carbon (CH2) of the selected 1,4-cis,cis-pentadiene unit on the
fatty acid substrate, and is followed by regioselective dioxygen
addition on the opposite face of the substrate either at ⫺2 or ⫹2
carbon (Fig. 1) (6). For such specific reactions to take place, a
very distinct substrate channel that goes past the non-heme
iron must position the fatty acid. This binding site must also
vary among LOX isoforms to facilitate the different catalytic
properties. The substrate-binding cavity has been described as
“boot-shaped”; it is directly accessible from the surface of the
protein and ends with a hydrophobic pocket (7). The pocket
residues of several 12/15-LOXs have been mutated to demonstrate that bulkier side chains favor 15-lipoxygenation, whereas
less space-filling residues, which would allow the fatty acid tail
to penetrate deeper into the cavity, confer 12-LOX activity.
These results are consistent with aliphatic tail-first entry
(8 –12). Also, a cationic arginine near the entrance of the cavity
has been shown to stabilize the carboxylate head of the fatty
acid (13). Computational docking studies based on x-ray crystallography data further support the boot-shaped substrate
channel (14, 15). For some LOXs, carboxylate head-first binding has been suggested to explain differing specificity or double
dioxygenation of AA (16, 17). In the light of the coral 8R-LOX
crystal structure, however, a novel binding model was proposed
with an alternative U-shaped channel that neglects the hydrophobic pocket (18). According to this hypothesis, the substrate
is bound in a culvert that runs under a conserved arched helix;
distinct lipoxygenases allow access to the catalytic iron from
one of two possible directions. Although several lipoxygenase
crystal structure models have been published, including rabbit
12/15-LOX (19, 20), coral 8R-LOX (18, 21), and recently a modified human 5-LOX (22) representing Animalia, the lack of
experimental evidence on substrate binding, such as a crystallized enzyme-substrate complex, has precluded the emergence
of a uniform theory.
The activity of various LOXs depends more or less on the
presence of Ca2⫹ that promotes interactions with the lipid
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FIGURE 1. All 12 possible lipoxygenation positions in AA. The catalysis begins with stereoselective hydrogen abstraction from C7, C10, or C13 (labeled
proS/R), followed by antarafacial dioxygen addition either at ⫺2 or ⫹2 carbon (grouped by colors). Based on data from Ref. 6.

membrane, from where the enzyme obtains its fatty acid substrate (21, 23). The human 5-LOX is effectively translocated to
the nuclear envelope upon Ca2⫹ release, the C2-like PLAT
domain being the selective membrane-targeting module (24).
The calcium-binding sites of the PLAT domain appear to be
conserved among human 5-LOX, coral 8R-LOX, gangrene
␣-toxin, as well as coral 11R-LOX, which are all induced by
Ca2⫹, but not in rabbit 12/15-LOX, which is only mildly
affected (21, 25). The molecular mechanism of Ca2⫹- and
membrane-induced allosteric regulation is not clear. Although
many mammalian lipoxygenases retain their reaction specificity after PLAT domain truncation, this is accompanied by
reduced turnover rates (26). Moreover, tight association of
PLAT and catalytic domains has been shown to be important
for protein stability and catalytic activity (27). A possible structural element that may be under allosteric control is the ␣2
region that forms a “lid” over the putative substrate channel
entrance, which can adopt different conformations, thereby
either opening or closing the orifice (20, 28, 29). Another plausible allosteric mechanism could involve oligomerization,
which has been noticed in case of human platelet 12-LOX and
rabbit 12/15-LOX (30, 31), but no definite assembly has been
described to date.
The arachidonate 11R-LOX from the white sea coral
Gersemia fruticosa is the first described lipoxygenase with 11Rspecificity (25). Based on primary structure comparison it is
most closely related to the 8R-LOX from the allene oxide synthase-lipoxygenase fusion protein of the Caribbean sea whip
coral Plexaura homomalla (42% identity) (32) and the analogous enzyme from G. fruticosa (43%) (33). The closest mammalian counterparts are 5-LOXs (about 33%). Experiments with
alternative substrates suggest that the fatty acid enters the
active site tail-first, as the catalysis specificity depends on the
distance of the bisallylic methylene from the methyl end of
the aliphatic tail (25). The conserved Gly/Ala sequence determinant, which acts like a switch that directs oxygen to either ⫺2
or ⫹2 carbon (R- or S-stereospecificity, respectively) (34), has
been identified as Gly416 (25), which agrees with previous findings linking glycine to R-stereoconfiguration. An important
feature of the 11R-LOX is its complete dependence on both
Ca2⫹ and lipid membranes, the presence of both components is
necessary for catalytic activity (25). This, together with the
remarkable stability and relative similarity of the enzyme to
human 5-LOX, makes it an exceptional subject to study the
mechanism of lipoxygenase catalysis specificity and regulation.
Hereby we report the 2.47-Å crystal structure model of the
coral 11R-LOX that suggests a potential allosteric mechanism
involving the PLAT domain and the ␣2 lid region. A highly

22378 JOURNAL OF BIOLOGICAL CHEMISTRY

conserved -cation bridge was found that could mediate the
regulatory effect of the PLAT domain to the active site. Additionally, a mutation analysis of the hydrophobic pocket in the
boot-shaped cavity was conducted to address questions regarding substrate binding. A general hypothesis of possible substrate orientations in the active site is described.

EXPERIMENTAL PROCEDURES
Expression and Purification—Recombinant G. fruticosa 11RLOX with an N-terminal His4 tag in pET-11a vector was transformed into Escherichia coli BL21(DE3) cells (Novagen). Colonies were grown overnight in 25 ml of LB containing 100 g/ml
of ampicillin at 37 °C. A 500-ml volume of autoinducing
medium ZYM-5052 (35) (with 100 g/ml ampicillin) was inoculated with 5 ml of overnight culture. The culture was incubated at 37 °C for 3– 4 h, followed by growth to saturation at
20 °C. Cells were harvested by centrifugation and frozen at
⫺80 °C when the absorbance at 600 nm had remained stable for
4 h (usually 27–30 h after the inoculation).
Cell pellets were resuspended in Bugbuster (Novagen) with
added DNase I, pepstatin, and PMSF. The suspension was
stirred and incubated on ice for 30 min, lysed in a French pressure cell, and centrifuged at 39,000 ⫻ g for 40 min at 4 °C. The
supernatant was applied onto a HisTrap Ni-Sepharose column
(GE Healthcare) and washed with binding buffer (50 mM TrisHCl, 500 mM NaCl, 20 mM imidazole, pH 8.0) on an ÄKTA
FPLC system (GE Healthcare). The protein was eluted with an
imidazole gradient from 20 to 200 mM. Protein fractions were
dialyzed overnight against 20 mM Tris-HCl, pH 8.0, or desalted
in a Sephadex G-25 Fine column (Amersham Biosciences). The
sample was then applied onto a Mono Q anion exchanger (GE
Healthcare), washed with 20 mM Tris-HCl, pH 8.0, and eluted
with a NaCl gradient from 0 to 500 mM. Concentrated protein
fractions were run on a Superdex 200 size exclusion column
(GE Healthcare) with 20 mM Tris-HCl, pH 8.0, and 150 mM
NaCl. For long term storage, the protein was concentrated to
⬃15 mg/ml, flash frozen in liquid nitrogen, and stored at
⫺80 °C.
Protein Crystallization—Showers of plate-like crystals
formed in 1–2-day-old hanging-drop vapor diffusion experiments that contained a 1:1 mixture of 5 mg/ml of protein solution and reservoir solution (0.1 M bis-Tris, pH 7.2, 11–12%
(w/v) PEG 3350, 15% (w/v) sucrose) at 22 °C. To obtain fewer
and bigger crystals a microseed stock was prepared using the
Seed Bead (Hampton Research) in stabilizing solution with 0.1
M bis-Tris, pH 7.2, 9% (w/v) PEG 3350, and 15% (w/v) sucrose.
Seeding experiments were conducted with drops containing
2:1:1 mixture of protein and reservoir solution as described
VOLUME 287 • NUMBER 26 • JUNE 22, 2012
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above and serial dilutions of seed stock as described in the Seed
Bead user guide. Larger single crystals grew in 2–3 days. For
cryoprotection, crystals were transferred into 0.1 M bis-Tris, pH
7.2, 12% (w/v) PEG 3350, 20 –25% (w/v) sucrose in two consecutive steps and then frozen in liquid nitrogen or a 100 K
cryostream.
Data Collection and Structure Determination—Preliminary
screens for crystal diffraction were conducted at the Gulf Coast
Protein Crystallography Consortium beamline at the Center for
Advanced Microstructures and Devices (CAMD, Louisiana
State University). A full dataset was collected at the NE-CAT
beamline 24-ID-E at the Advanced Photon Source (Argonne,
IL) using 0.98-Å radiation at 100 K. Data were processed to a
resolution of 2.47 Å (Table 1) using xia2 (36). The structure was
determined by molecular replacement with MrBUMP (37, 38)
using 3.2-Å P. homomalla 8R-LOX model (PDB code 2fnq).
The initial refinement cycles were performed with REFMAC5
(39). Both MrBUMP and REFMAC5 are part of the CCP4
suite (40). Manual model building was done with COOT (41)
and further refinement in PHENIX (42) using the program
phenix.refine with non-crystallographic symmetry and Ramachandran restraints, individual isotropic atomic displacement
factors, and automatic water picking. For the final refinement,
hydrogens were added to the model, Ramachandran restraints
were released and both stereochemistry and atomic displacement weights were optimized. Illustrations were prepared with
UCSF Chimera (43), surfaces were obtained with MS-MS (44).
The dimerization interface was analyzed using PISA (Protein
Interfaces, Surfaces and Assemblies) (European Bioinformatics
Institute) (45). Sequences were aligned with ClustalW2 (46)
and rendered with ESPript (47).
Site-directed Mutagenesis—The V430A, L431A, V609A, and
V609W mutations were introduced using whole plasmid PCR
primed with complementary primers that additionally contained silent mutations for restriction analysis. The M606A
mutant was obtained by separately cloning the upstream and
downstream fragments of the recombinant cDNA using mutation-containing primers with respective cDNA upstream or
downstream primers. Purified fragments were merged using
PCR and the cDNA was ligated back into pET-11a vector (Stratagene) into the BamHI site. The desired mutations were confirmed by sequencing. For whole plasmid PCR protocol, the
following DNA primers were used with their complementary
primers for mutagenesis: 5⬘-GGT GCG GCT GAC AAA GCG
CTG AGC ATT GGT GGA GG-3⬘ for V430A, 5⬘-GGT GCG
GCT GAC AAG GTG GCT AGC ATT GGT GGA GG-3⬘ for
L431A, 5⬘-GTT ACA ATG GTT TCA GCT GTG AAT GCG
C-3⬘ for V609A, 5⬘-ACA ATG GTT TCT TGG GTT AAC GCG
CTA ACC ACG A-3⬘ for V609W, and the following primers for
cloning fragments with M606A mutation: 5⬘-AA GGA TCC
ATG CAT CAC CAT CAC ATG AAG TAC AAG-3⬘ (11RLOX cDNA upstream) and 5⬘-G CGC ATT CAC AAC AGA
AAC AGC TGT AAC AGC TTG-3⬘ (M606A downstream) for
the upstream fragment, 5⬘-CAA GCT GTT ACA GCT GTT
TCT GTT GTG AAT GCG C-3⬘ (M606A upstream) and
5⬘-GAT GGA TCC TTA GAT GGC AAT ACT GTT CGG-3⬘
(11R-LOX cDNA downstream) for the downstream fragment.
JUNE 22, 2012 • VOLUME 287 • NUMBER 26

Enzyme Assay—Initial enzyme specificity experiments were
conducted on crude bacterial lysates. BL21-CodonPlus(DE3)RP cells (Stratagene) were transformed and grown in LB
medium with 100 g/ml of ampicillin at 37 °C. Following 500
M isopropyl ␤-D-thiogalactoside induction at A600 nm ⫽ 0.6,
cells were grown for 16 –18 h at 10 °C. Cells were harvested by
centrifugation at 4 °C, washed with 50 mM Tris-HCl, pH 8.0,
aliquoted, and frozen at ⫺80 °C.
For product analysis, aliquots of 2.5 ml of culture were resuspended in 500 l of 50 mM Tris-HCl, pH 8.0, with 1 mM PMSF
and sonicated 3 ⫻ 5 s using a Torbéo 36810-Series cell disruptor (Cole Parmer) at a setting of 5. The suspension was centrifuged at 13,000 ⫻ g for 20 min at 4 °C and the supernatant was
harvested. CaCl2 was added to the enzyme solution in final
concentration of 10 mM. Incubations of 1–20 ml were carried
out in 50 mM Tris-HCl, 250 mM NaCl, pH 9.0 buffer with 50 M
arachidonic acid at room temperature for 5 min with constant
stirring. [1-14C]-Labeled arachidonic acid (GE Healthcare) was
used in 1-ml incubations. HpETEs were reduced to corresponding hydroxy acids (HETEs) with 10 mM SnCl2, the mixture was acidified with KH2PO4/HCl (1:1) to pH 6 and the products were extracted using ethyl acetate. Incubation products
(10 –20 ml volumes) were purified prior to HPLC analysis using
thin layer chromatography: the extract was applied on a silica
gel plate, eluted with a hexane/ethyl acetate/acetic acid (3:4:
0.05) mixture, and the product band was determined using UV
light (254 nm) and extracted with methanol.
For kinetic studies, wild-type enzyme and selected mutants
were purified on an ÄKTA FPLC system as described above.
Conjugated diene formation was monitored on a UV-1601
spectrophotometer (Shimadzu) at 236 nm. Reactions of 1 ml
(50 mM Tris-HCl, pH 8.0, 100 mM NaCl, 2 mM CaCl2, ⬃60 M
liposome) were performed in a thermostatted (20 °C) cuvette
with continuous stirring. The concentration of arachidonic
acid (Cayman) was varied from 2 to 200 M. The reaction was
initiated by adding 6 nM wild-type enzyme, or up to 32 nM for
the less active mutants. The reaction velocity was determined
from the slope of the linear portion of the curve. Km and kcat
values were obtained by nonlinear regression analysis with the
Michaelis-Menten equation. As 11R-LOX exhibits very strong
substrate inhibition and, thus far, no suitable kinetic model has
been derived, only the ascending part of the curve (2–30 M
AA) was used for fitting.
HPLC-MS Analysis—Catalysis products were analyzed by
reverse phase HPLC using an Agilent Eclipse 3.5 m 150 ⫻
2.1-mm ODS column thermostatted at 35 °C. The sample was
eluted isocratically with methanol/water/acetic acid (75:25:
0.01, v/v/v) at 0.25 ml/min on an Agilent 2200 Series HPLC
system. Products were detected using a diode array detector
monitoring wavelengths 210 –280 nm, followed by an Agilent
LC/MSD Trap XCT mass spectrometer. The MS/MS spectra of
arachidonic acid derivates were obtained in negative mode
using an APCI interface.
[1-14C]-Labeled products were additionally analyzed using a
Radiomatic 500TR Flow Scintillation Analyzer (Packard Bioscience) preceded by an Agilent Eclipse 5 m 150 ⫻ 4.6-mm ODS
column thermostatted at 35 °C and a diode array detector. The
same eluent was used at a flow rate of 1 ml/min.
JOURNAL OF BIOLOGICAL CHEMISTRY
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TABLE 1
Data collection and refinement statistics
Data collection
Space group
Cell dimensions
a, b, c (Å)
␣, ␤, ␥ (°)
Resolution (Å)
Rsymb
I/I
Completeness (%)
Redundancy

C2
114.80 148.71 117.33
90.00 119.16 90.00
36.48–2.47 (2.54–2.47)a
0.072 (0.474)
10.1 (1.7)
97.1 (84.6)
3.0 (2.3)

Refinement
Resolution (Å)
No. of reflections
Rwork/Rfreec
No. of atoms
Protein
Iron
Sucrose
Water
B-factor (Å2)
Protein
Iron
Sucrose
Water
Root mean square deviation
Bond lengths (Å)
Bond angles (°)

36.48–2.47
57,423
0.2019/0.2281
10,880
2
46
482
42.9
36.3
56.9
39.0
0.005
0.6

a

Values in the parentheses represent the highest resolution shell.
Rsym ⫽ ⌺h⌺l兩Ihl ⫺ 具Ih典兩/⌺h⌺l具Ih典, where Ihl is the intensity of the lth observation
and 具Ih典 is the mean intensity of the reflection h.
c
R ⫽ ⌺储Fo兩 ⫺ 兩 Fc 储/⌺兩Fo兩, where Fo and Fc are the observed and calculated structure factor amplitudes, respectively. Rfree was calculated using 3.33% of the total
reflections.
b

To analyze the chirality of HETEs, the products were purified
in a normal phase HPLC system using a Phenomenex Luna 5
m 250 ⫻ 4.6-mm Silica column in isopropyl alcohol (1%
H2O)/hexane (7:93, v/v) at 1 ml/min. HETEs were methylated
using diazomethane and analyzed using a Chiralcel OD-H
250 ⫻ 4.6-mm column in 0.7% isopropyl alcohol (dry), 0.7%
methanol, hexane (v/v/v) at 1 ml/min.
Liposome Preparation—Small unilamellar vesicles were prepared from L-␣-phosphatidylcholine, L-␣-phosphatidylethanolamine, and L-␣-phosphatidylserine (Avanti Polar Lipids). A
mixture of phosphatidylcholine/phosphatidylethanolamine/
phosphatidylserine (40:30:30 mol %) in chloroform was dried in
a round-bottom flask using a nitrogen stream to form a thin
film and was incubated in vacuum for 1 h at room temperature.
Buffer (50 mM Tris-HCl, 100 mM NaCl, pH 8.0) was added to
the dried lipids and the film was soaked for 1 h. The suspension
was shaken vigorously, sonicated 15 ⫻ 5 s on a Torbéo 36810Series cell disruptor (Cole Parmer) with 1-min intervals at the
setting of 5 in a water bath at room temperature. The sonicate
was centrifuged at 13,000 ⫻ g for 20 min at 4 °C. The supernatant was saved and stored at 4 °C.

RESULTS
Overall Structure—The crystal structure of 11R-LOX in a
calcium-free environment was refined at 2.47 Å with Rwork and
Rfree values of 0.20 and 0.23, respectively (Table 1). The protein
crystallized in space group C2 with two molecules in the asymmetric unit. Phasing was done with molecular replacement
using P. homomalla 8R-LOX (PBD code 2fnq) as a template. A
total of 96.1% of the residues are in the favored region of the
Ramachandran plot and there are no outliers according to MolProbity validation (48).
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Like the majority of lipoxygenases, 11R-LOX consists of two
distinct domains: the N-terminal C2-like PLAT domain (residues 1–115) and a larger mainly ␣-helical catalytic domain (residues 129 – 679), which are connected by a small linker region
(residues 116 –128). The catalytic domain contains the nonheme iron, which is coordinated by three highly conserved histidines, His373, His378, and His556, and the carboxylate group
of the C-terminal Ile679. In general, the structure is very similar
to that of the 8R-LOX domain of P. homomalla allene oxide
synthase-LOX fusion protein, a root mean square deviation of
644 C␣ pairs being 1.37 Å. The greatest differences are found in
the putative entrance to the active site, which more closely
resembles the recently published human Stable-5-LOX (22).
Similarly to 5-LOX, the ␣2 helix of 11R-LOX that covers the
putative entrance is only about 2 turns long and is flanked by
loops and small 310-helices. It should also be mentioned that
the overall similarity between the 11R- and 5-LOX is very high
(root mean square deviation of 641 C␣ pairs is 1.49 Å).
Another heterogeneous region includes the putative Ca2⫹binding sites in the PLAT domain. The PLAT domain is a
␤-sandwich consisting of two antiparallel 4-strand ␤-sheets. At
the sheets’ ends proximal to the catalytic domain (opposite to
the N terminus) there are four loops that connect the two
sheets, three of the loops being rather extensive, this is the
region that contains the Ca2⫹-binding sites. The electron density map is less clear in the region of the PLAT domain, which is
characterized by higher mean B-factors, 37.3 Å2 for the catalytic domain versus 70.5 Å2 in the PLAT domain. The least well
defined densities are found in the putative calcium-binding
loops, especially residues His43–Glu47 and Gly73–Lys77;
whereas main chain density is not ambiguous, several side
chains were modeled primarily according to optimal geometry
(side chains present at ⱖ0.5 ). For refinement, all occupancies
were set to 1. The apparent mobility of these residues is
described by their elevated B-factors.
Dimerization—Size exclusion chromatography indicated
that 11R-LOX appears as a dimer in a calcium-free buffer. The
purified enzyme eluted with aldolase (158 kDa), which is double
the molecular mass of the recombinant protein (79 kDa) (supplemental Fig. S1). Based on ultrafiltration assays, it was previously concluded that 11R-LOX is in a monomeric state in solution: in calcium-free conditions the enzyme passed a filter with
a 100-kDa cutoff without major losses (25). The findings presented here clearly dispute those claims. In the presence of 10
mM CaCl2, however, size exclusion chromatography analysis
indicated the formation of large aggregates, as the protein
eluted with the void volume (data not shown). Similar results
were obtained using ultrafiltration (25). Potential dimerization
interfaces were searched among the crystal contacts using PISA
(45), but according to the criteria established by the algorithm,
no significant assemblies were found.
Substrate Channel and Its Entrances—There is an array of
consecutive, mostly hydrophobic cavities concealed in the catalytic domain alongside the coordinated non-heme iron (Fig.
2). These cavities are covered by a conserved arched helix
(␣10 –␣11 in G. fruticosa), and the potential entrances on either
side are blocked by short helices and loops. The arched helix
harbors the R/S-stereospecificity determinant Gly416 (34).
VOLUME 287 • NUMBER 26 • JUNE 22, 2012
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FIGURE 2. The active site and its accessibility. A, the active site with the non-heme iron (sphere) and substrate binding cavities (cyan and green surfaces) are
covered by the conserved arched helix ␣10 –␣11 (blue). Potential entrances A and B (arrows) are blocked by Phe185 and Tyr154 (red residues), respectively. Both
have an arginine in the vicinity that could stabilize the carboxylate head of the fatty acid substrate. The entrances are covered by the lid segment (gold) that
interacts with the PLAT domain (orange) near the loops, which contain the putative Ca2⫹-binding sites (magenta), via a -cation bridge (Trp107–Lys172).
Additionally, there are hydrophobic residues in the C-terminal part of the lid that could bind the lipid membrane. B, in the active site, the non-heme iron is
coordinated by highly conserved residues (orange). The volume of the hydrophobic pocket (light green) has been found to be important in catalysis specificity
(7, 12). Residues marked in green were mutated in this study to investigate that hypothesis. Another set of cavities (cyan) could give access to the active site via
the alternative entrance B. C, schematic depictions of hypothesized substrate-binding channels and substrate orientations (viewing angle is analogous to
panels A and B). The boot-shaped cavity is defined as a passage from entrance A to the bottom of the hydrophobic pocket (7, 12). The U-shaped channel would
stretch between the two entrances (18). Yet another possibility is that the fatty acid tail is always bound into the hydrophobic pocket, but either one of the
entrances is used depending on the enzyme isoform, this yields the T-shaped channel.

There is a small confined chamber (about 34 Å3) next to the
catalytic iron that is surrounded by several conserved aliphatic
residues, which have been thoroughly discussed in P.
homomalla 8R-LOX by Neau et al. (18). Of those residues,
Leu374, Leu420, and Leu613 form an orifice that leads to the largest cavity (188 Å3), which is located under the arched helix
toward the “rear” end of the enzyme (away from the PLAT
domain). The bottom of this cavity is composed of residues
Thr365, Val430, and Val609, which coincide with the regiospecificity determinants described for the boot-shaped channel in
12/15-LOX (7); Leu431, also a regiospecificity determinant of
some LOXs (8, 12); and Met606, a position claimed to be relevant in the binding orientation of the fatty acid substrate (49).
On one side of the arched helix, the entrance to the active site
chamber is blocked by Phe185 that sits on a loop between helices
4 (310-helix) and ␣2. On the other side, a gap between Leu374,
Ile412, and Leu420 leads to a pair of cavities (95 and 113 Å3) that
also reach toward the protein surface. These cavities are lined
JUNE 22, 2012 • VOLUME 287 • NUMBER 26

perpendicularly to the largest one, and are separated from each
other by a constriction formed by Leu379, Ile421, and a conserved salt bridge Glu382–Arg417, that participates in lodging
the arched helix. Access on this side is obstructed by Tyr154 and
the loop where that residue is situated.
Let us call the orifices blocked by Phe185 and Tyr154
entrances A and B, respectively. Both of these entrances have a
positively charged residue in the vicinity, which could neutralize the carboxylate group of a fatty acid, and therefore, aid to
position the substrate for catalysis: these are Arg186 for
entrance A, and Arg153 for B. It is interesting to note that the
chain fragments that constitute the lids over both entrances
interact with the PLAT domain, there is a -cation interaction
between Trp107 and Lys172, as well as an H-bond connecting the
main chain N-H of Trp107 with Asp173 (Fig. 2A). The lids of
entrances A and B are on the C- and N-terminal sides of the
interface, respectively. Therefore, either one of the entrances
could be regulated via this bridge. The -cation bond appears
JOURNAL OF BIOLOGICAL CHEMISTRY
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FIGURE 3. The conserved -cation bridge binds the regulatory PLAT and
the catalytic domains. A, superposition of 11R-LOX (white), rabbit 12/15-LOX
(gray), human 5-LOX (orange), and soybean LOX-1 (green) reveals the common interface. B, partial sequence alignments of the PLAT domain and the lid
that establish the -cation bridge. The PLAT domain Trp107 is invariant, the
cationic residue can be found in either of the two positions (blue arrows).

to be conserved as it is present in all published lipoxygenase
crystal structures (18, 20, 22, 50 –53) (Fig. 3A). The PLAT
domain Trp107 is invariant among studied LOXs and is a part of
the conserved sequence FPCYRW on the ␤7 strand of animal
LOX (28). The cationic residue of the catalytic domain (Lys172
in 11R-LOX) is more variable, but can still be found in either of
the two positions shown on the alignment (Fig. 3B).
Ca2⫹-binding Sites—The 11R-LOX crystals were obtained in
calcium-free conditions, but for catalytic activity, the presence
of Ca2⫹ is a must. When compared with available structures of
Ca2⫹-PLAT complexes, the Ca2⫹-binding loops of the apo-domain in 11R-LOX differ significantly. The PLAT domains of
coral 8R-LOX (21) and gangrene ␣-toxin (54) both contain
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FIGURE 4. The PLAT domain and putative Ca2ⴙ-binding sites. A, superposition of the coral 8R-LOX Ca2⫹–PLAT complex (green) and the 11R-LOX apoPLAT (orange). The invariant Trp is situated on the ␤7-strand right next to site
III. B, conservation of binding sites, conserved residues are in red. 11R-LOX,
8R-LOX, and gangrene ␣-toxin are aligned according to a structural superposition; human 5-LOX is aligned according to sequence. Residues that constitute sites I (blue), II (red), and III (green) in 8R-LOX and ␣-toxin are denoted by
circles (empty if participates by main chain, filled if by side chain atom). The
invariant Trp is indicated by a star.

three occupied binding sites, these are formed by three adjacent
loops and are well conserved both in sequence and structure
(21). All three sites are also preserved in the 11R-LOX
sequence, yet are absent in the tertiary structure (Fig. 4). The
first Ca2⫹ complex is formed by a turn in the ␤3–␤4 loop; in the
apo-PLAT domain the turn is missing, and instead, there is an
extra ␤-strand-like segment. The second site is situated
between another turn in the ␤3–␤4 loop and ␤1–␤2 loop; again,
the loops in 11R-LOX are arranged differently making a
VOLUME 287 • NUMBER 26 • JUNE 22, 2012
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TABLE 2
Positional specificity of 11R-LOX (%)

TABLE 3
Kinetic properties of wild-type 11R-LOX and selected mutants

Arachidonic acid was incubated with the bacterial crude lysate, reaction products
were analyzed by RP-HPLC-MS. Chromatograms and MS/MS spectra are provided
in supplemental Fig. S3 and S4.

All enzymes were readily purified and analyzed as described under “Experimental
Procedures.”

a
b

Enzyme

15-HpETE

11-HpETE

8(/12)-HpETE

5-HpETE

WT
V430A
V609A
L431A
M606A
V609W

2
1
8
3
2
23

98
99
91
87
89
69

NDa
ND
1
10
9
3b

ND
ND
ND
ND
ND
5

ND, not detected.
8- and 12-HETE did not separate in the HPLC system, but both derivates were
detected by MS for V609W.

smoother curve and reaching further away from the ␤-sandwich core. The same goes for the third site that lies between a
turn in the ␤1–␤2 loop and the ␤5–␤6 loop. Site III is also the
hardest to detect by sequence comparison as it is mostly defined
by main chain atoms. Fig. 4 illustrates that the Ca2⫹-binding
sites are intertwined; therefore, a cascade of conformational
changes could occur upon metal chelation. The aforementioned Trp107 is right next to site III and makes contacts with
residues that define the site in both apo- and holo-PLAT
domains. This suggests it could be communicating the allosteric effect that occurs upon calcium and membrane binding in
the PLAT domain to the lid segment.
Site-directed Mutagenesis of Substrate Channel—Several residues were mutated in the largest of the internal cavities to
study its intrinsic role in the specificity of catalysis. Bulky,
hydrophobic Val430, Leu431, Met606, and Val609 were substituted with a compact alanine to deepen the boot-shaped channel, and potentially alter the regiospecificity of the enzyme, as
has been previously shown by Kühn et al. (7). In the case of
11R-LOX, the additional space was expected to cause a frameshift of substrate binding, resulting in a novel 8-LOX activity,
unseen in the wild-type. The V430A and V609A substitutions
failed to alter the position of hydrogen abstraction, although
the corresponding residues have been described as regiospecificity determinants for rabbit 12/15-LOX (11) and many others
(12) (full sequence alignment is provided in supplemental Fig.
S2). Rather, the V609A mutant suffered from general loss of
positional control, exhibiting increased 15-HpETE production
(Table 2). On the other hand, modest 8-LOX activity was
observed with L431A and M606A mutants, reaching up to 10%
of 8-HpETE production. Further kinetic studies of those
enzymes showed that there was no remarkable change in substrate affinity (Km) (Table 3). However, the catalysis efficiency
(kcat/Km) of the L431A mutant was only one-fourth of the wildtype as the turnover rate (kcat) had dropped. One possible interpretation of this data is that the substrate cannot align in an
orientation appropriate for hydrogen abstraction as the hydrophobic pocket has a role in substrate positioning. Granted, the
data do not rule out an effect on the catalytic machinery itself,
but the fact that enzyme retains catalytic activity might suggest
that the iron coordination sphere remains intact. Moreover, the
residue at this position varies significantly among LOX isoforms so it is in all likelihood not an essential element of the
core LOX fold.
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Enzyme
WT
L431A
M606A
V609W

kcat

Km

s⫺1

M

310.7 ⫾ 24.6
50.6 ⫾ 3.3
398.0 ⫾ 20.8
5.8 ⫾ 0.6

12.3 ⫾ 2.2
7.8 ⫾ 1.4
13.7 ⫾ 1.5
12.4 ⫾ 3.0

kcat/Km
25.2
6.5
29.0
0.5

Although the data display a trend, these studies do not rule
out the use of the alternative U-shaped channel (Fig. 2C). To
find more substantial evidence to differentiate between the
channels, Val609, which lies near the proximal side of the hydrophobic pocket, was substituted with a large tryptophan to block
the distal end of the cavity, and propagate the usage of the
U-shaped channel. As a consequence, the catalytic efficiency of
the enzyme plunged 50-fold, but surprisingly, the Km remained
unaffected despite the dramatic reduction in binding space that
such a mutation should have caused. Apparently, the loss of
activity was entirely due to the diminished turnover rate (Table
3). Reaction specificity suffered greatly, as well, as the share of
11-HpETE dropped down to 69% and a multitude of by-products (15/5/8/12-HpETE in descending order by proportion)
was formed (Table 2). The chirality of the three major products
of V609W mutant, 11/15/5-HpETE, was determined using chiral phase HPLC, to confirm the substrate orientation in the
active site. Practically pure 11R and 5S products were detected,
oxygenation at C15 created an R/S (35:65) mixture (data not
shown). The formation of 5S-HpETE intimates a head-first
binding if entrance A is considered as the point of entry,
whereas for 11R-HpETE, tail-first orientation has been suggested (25).
The interpretation of these data is not straightforward. If one
invokes the use of the boot-shaped cavity, the residual activity
of the V609W mutant may be a result of incomplete closure of
the cavity and a motional flexibility to allow room for substrate
entry despite the bulky tryptophan (Fig. 2C). On the other hand,
if the fatty acid binds into the U-shaped channel, the role of the
hydrophobic pocket may be to provide the flexibility necessary
for the substrate to product transition. This would easily
explain the unchanged Km. Nevertheless, the various regiospecificities of distinct LOXs must somehow be reflected by
their binding sites (e.g. different cavity volumes). The U-shaped
channel is highly conserved, as emphasized by Neau et al. (18),
but the invariant amino acids alone cannot explain the distinct
products among lipoxygenases. Those side chains that impart
specificity would be expected to lie outside the cluster of conserved amino acids. The hydrophobic pocket fulfills that criterion, and binding of AA in that cavity is supported by product
shifts in L431A and M606A mutants.

DISCUSSION
Allosteric Lid Segment—The substrate channel entrance A of
11R-LOX is blocked by Phe185. Interestingly, a similar element,
a Phe-Tyr “cork,” has been described in human 5-LOX (22).
This cork is situated where the other LOX crystal structure
models are open to allow access to the catalytic site. In these
JOURNAL OF BIOLOGICAL CHEMISTRY
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FIGURE 5. Superposed 11R-LOX (orange) and human 5-LOX (green) lid
segments. In 5-LOX, entrance A is blocked by a Phe177–Tyr181 cork (22), the
11R-LOX counterpart of which is Phe185. For entrance B, the corks are Trp147
and Tyr154, respectively. Both structures include the conserved -cation
bridge and several hydrophobic residues in the C-terminal part, which could
anchor into the lipid membrane.

two structures, however, the ␣2 helix is considerably shorter
and is flanked by loops and 310-helices forming a lid that covers
entrance A (Fig. 5). In the N-terminal end of this motif is the
conserved -cation bridge (Trp107–Lys172) that connects the
PLAT and the catalytic domain. The -cation bridge is preceded in turn by the lid of entrance B, with Tyr154 blocking the
access. The corresponding cork in human 5-LOX is Trp147, and
again, the similarity between the coral and human enzyme lids
is remarkable. Notably, this is the entrance Gilbert et al. (22)
have suggested to be utilized in 5-LOX, as opening it requires
only a rotamer flip, and this way the substrate can enter the
channel “tail first.” The stereochemistry of the products of 5and 11R-LOX suggests that AA is bound in inverse orientations
in these enzymes: may it be a result of the substrate entering
the active site in inverse orientation using the same orifice or
the utilization of different entrances. In either case, access to
the catalytic site in both enzymes requires a conformational
change, an opening of the lid. The structure of 11R-LOX can
provide a stable framework for understanding the relationship
between Ca2⫹-dependent membrane binding and lid opening.
It has been speculated that the interface of PLAT and catalytic domains, including the conserved FPCYRW fragment on
the ␤7 strand, might be involved in an allosteric regulatory
mechanism, transmitting a conformational change in the PLAT
domain induced by calcium and membrane binding to the lid
component in the catalytic domain (28). We propose, that the
conserved -cation bond could be mediating this interaction,
as it stands right between the Ca2⫹-binding sites and the allosteric lid. The different regulatory properties of various lipoxygenases (e.g. the necessity of calcium and membranes for 11RLOX catalysis) can be explained by differing conditions that are
needed to set off the cascade of conformational changes, which
among other contributors depend strongly on the structure of
the Ca2⫹-binding loops (55). The activity that is present without any inducing factors in most LOXs can be attributed to a
semi-open orifice, or possibly allosteric binding of the substrate
itself. Additionally, in human 5-LOX the FPCYRW fragment
has been shown to be involved in the binding of the coactosinlike protein, which promotes leukotriene formation (56).
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Although the exact mechanism of the latter is unknown, it further substantiates the regulatory role of the bridge.
In 11R-LOX, entrance A seems the more plausible access
route for several reasons. First, the same orifice is used in rabbit
15S-LOX according to docking studies (14). For 11R- and 15Sspecificity, the same hydrogen must be abstracted in the initial
step of catalysis; thus, substrate binding should also be identical. Second, coral 8R-LOX, the binding of which should differ
from 11R- and 15S-LOX only by “frameshift,” has been suggested to employ entrance A as well (18). Another detail in favor
of entrance A is that there are several bulky, hydrophobic residues like Phe192, Phe201, and Trp204 on the C-terminal end of its
lid fragment, distal to the PLAT domain interface (Fig. 5). With
slight conformational changes, these residues could readily
anchor the catalytic domain to the lipid membrane, and facilitate an additional mechanism of lid removal. Analogous residues are present in other lipoxygenases, too, including human
5-LOX. Furthermore, the entrance A lid is followed by the putative PDZ domain, which might also contribute to allosteric regulation, making this opening the more likely candidate not only
for 11R-LOX, but for other LOXs as well.
Additional experimental data are essential to elucidate the
possible access portals in this family of enzymes. In a recent
experiment, removing the entrance A cork of olive LOX1 by
site-directed mutagenesis augmented the activity of the
enzyme remarkably (57). A similar approach could be used in
further study to determine the true substrate entrance of 11RLOX, but also of other LOXs.
T-shaped Substrate Channel—In general, the 11R-LOX
model contains a closed, roughly T-shaped system of cavities,
wherein the active site iron is located at the junction of perpendicular channels, and the potential entrances for the substrate
are situated at both ends of the “T-bar” (Fig. 2C). Although the
channel system seems to be segmented in the model, minimal
side chain movements are necessary to connect the neighboring pockets. In this system of cavities, the so called boot-shaped
channel described by Kühn et al. (7, 12) would constitute the
passage from entrance A to the bottom of the hydrophobic
pocket. The alternative U-shaped channel proposed by Neau et
al. (18), on the other hand, would consist of a culvert stretching
below the arched helix and connecting both entrances, and
thus, disregarding the pocket altogether.
The results obtained by site-directed mutagenesis of 11RLOX suggest that the integrity of the T-shaped channel is
required for proper positioning of the substrate. The fact that
L431A and M606A substitutions resulted in an 8/11-LOX,
albeit with modest amounts of the 8-product, suggests that AA
enters the hydrophobic pocket tail-first. This model is also
supported by the dramatic reduction of catalytic activity and
specificity when the pocket was blocked by the V609W substitution, even though the kinetic parameters for that mutant have
left room for alternative interpretations. It is likely that in
regard to substrate binding, 11R-LOX is analogous to the
enzymes described to have a boot-shaped channel (e.g. rabbit
12/15-LOX).
The presence of cavities that connect the hypothetical
entrance B with the active site still makes one question their
potential role. The U-shaped channel is lined with highly conVOLUME 287 • NUMBER 26 • JUNE 22, 2012
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served Leu and Ile residues that imply a structure-functional
importance. However, the highly conserved amino acids alone
cannot define the different catalytic properties of lipoxygenases. And whereas the cavity that forms the B side of the T-site
may provide an entry way for molecular oxygen access as suggested for soybean LOX-1 (58, 59), it is not clear whether leucines, as opposed to any hydrophobic amino acids, are necessary for an O2 channel. It just might be that distinct
lipoxygenases each utilize the central core of the binding site,
but regiospecificity is defined by the access to that core. One
could imagine a theory that merges the boot- and U-shaped
passages, yielding a T-shaped substrate channel. Depending on
the catalytic specificity of a particular LOX, the substrate could
enter tail-first utilizing either one T-bar entrances. Additional
mechanisms like positively charged residues could further
induce and stabilize the substrate binding. Yet, for specificity,
the aliphatic tail requires the internal hydrophobic pocket. Further studies, especially co-crystallization of the enzyme with the
substrate could bring more definitive answers to these matters.
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